It included 432 individuals over 12 years of age who had plaque psoriasis affecting up to 25% of the scalp and body, with a minimum scalp IGA score of 3 and body IGA score of 2. Average age was 47 ...

Scalp psoriasis often presents with persistent itch ... or 1 (almost clear) with a minimum two-grade reduction from baseline and a Body-Investigator Global Assessment score of 0 or 1 with the ...

It included 432 individuals over 12 years of age who had plaque psoriasis affecting up to 25% of the scalp and body, with a minimum scalp IGA score of 3 and body IGA score of 2. Average age was 47.3 ...

Johnson & Johnson (J&J) has reported new data from the Phase III ICONIC-TOTAL trial, assessing icotrokinra in treating plaque ...

Whether you’re dealing with dandruff, psoriasis, or just an itchy scalp ... a drop or two of oil serum to the affected area or scalp a minimum of one time daily, and gently massage the hydrating ...

The FDA approved a supplemental new drug application for roflumilast topical foam 0.3% for the treatment of plaque psoriasis ...

The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and ...

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis of the scalp and ...

Roflumilast foam, 0.3%, proved to be a simplified treatment regimen with high efficacy for patients with scalp and body ...